Calculate the QT interval in patients taking drugs for dementia

British Medical Journal

Volumn 335, Issue 7619, 2007, Pages 557-

  Leitch, Andrew ^a,b   McGinness, Peter ^a   Wallbridge, David ^a  

^a ROYAL SHREWSBURY HOSPITAL   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPRENALINE; MAGNESIUM; RIVASTIGMINE; DONEPEZIL; INDAN DERIVATIVE; NOOTROPIC AGENT; PIPERIDINE DERIVATIVE;

AGED; ARTICLE; BIOCHEMISTRY; BLOOD PRESSURE; CALCULATION; CASE REPORT; DEMENTIA; ELECTROCARDIOGRAM; FEMALE; HEART PACING; HOSPITAL ADMISSION; HUMAN; PATIENT REFERRAL; PHYSICIAN; PRIORITY JOURNAL; QT INTERVAL; SINUS BRADYCARDIA; CHEMICALLY INDUCED DISORDER; HEART VENTRICLE TACHYCARDIA; LONG QT SYNDROME;

AGED; DEMENTIA; FEMALE; HUMANS; INDANS; LONG QT SYNDROME; NOOTROPIC AGENTS; PIPERIDINES; TACHYCARDIA, VENTRICULAR;

EID: 34548813401     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.39020.710602.47     Document Type: Article

References (3)

1. De Ponti F, Poluzzi E, Montanaro N, Ferguson J. QTc and psychotropic drugs. Lancet 2000;356:75-6.
2. Medicines and Healthcare Products Regulatory Agency. Adverse drug reactions online information tracking: rivastigmine. www.mhra.gov.uk/home/ groups/public/documents/sentineldocuments/dap_1130236048936.pdf
3. Yap YG, Camm AJ. Drug induced QT prolongation and torsade de pointes. Heart 2003;89:1363-72.